Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Neoplasms

Explore clinical trials studying Head and Neck Neoplasms. Study availability and eligibility vary by location and protocol.

3,749 public trials 1,058 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Neoplasms trial results

Recruiting

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

NCT04389632

Conditions
Adenocarcinoma Of Esophagus, Adnexal Diseases, Bronchial Neoplasms, +52 more
Locations
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
View all 158 locations
View Trial Details
Recruiting

A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)

NCT07136545

Conditions
Carcinoma, Carcinoma, Squamous Cell, HNSCC, +6 more
Locations
  • Chang-Gung Memorial Hospital(Lin-Kou) Taoyuan, Guishan District, Taiwan
  • National Taiwan University Hospital Taipei, Taipei City, Taiwan
  • Taipei Veterans General Hospital Taipei, Taipei City, Taiwan
View Trial Details
Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

NCT07217171

Conditions
Anal Squamous Cell Carcinoma, Anus Diseases, Anus Neoplasms, +38 more
Locations
  • City of Hope Duarte, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
  • The Winship Cancer Institute Emory University Atlanta, Georgia, United States
View Trial Details
Recruiting

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

NCT06385080

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
Locations
  • University of California at San Diego Moores Cancer Center La Jolla, California, United States
  • University of Colorado Denver Anschultz Medical Campus Aurora, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • The University of Chicago Medical Center (UCMC) Chicago, Illinois, United States
View all 56 locations
View Trial Details
Recruiting

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

NCT07276399

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
Locations
  • Ironwood Cancer and Research Center Chandler, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Providence St Jude Medical Center Fullerton, California, United States
  • Scripps Health La Jolla, California, United States
View all 196 locations
View Trial Details
Recruiting

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

NCT07283939

Conditions
Ampulla of Vater Carcinoma, Appendiceal Neoplasms, Appendix Carcinoma, +28 more
Locations
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
View all 344 locations
View Trial Details
Recruiting

Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer

NCT07367516

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +7 more
Locations
  • The Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Gansu Provincial Tumor Hospital Lanzhou, Gansu, China
View all 30 locations
View Trial Details

Related conditions